Vilazodone is a serotonin partial agonist and reuptake inhibitor antidepressant indicated for the treatment of major depressive disorder. It functions through a dual mechanism, selectively inhibiting the… Read more

















































Vilazodone is a serotonin partial agonist and reuptake inhibitor antidepressant indicated for the treatment of major depressive disorder. It functions through a dual mechanism, selectively inhibiting the serotonin transporter while acting as a partial agonist at 5-HT1A receptors. Within this catalogue, Vilazodone and its associated compounds—including pharmacological impurities, metabolites, and stable isotope labelled standards—are essential for comprehensive pharmaceutical analysis. These reference standards are vital for accurate impurity profiling, supporting rigorous method validation, and ensuring consistent quality control throughout the drug development and manufacturing lifecycle. By providing precise characterization of degradation products and related chemical entities, these materials enable laboratories to meet stringent regulatory requirements for safety and efficacy. Each compound is designed to facilitate reliable testing, ensuring that the development and production of this antidepressant adhere to the highest analytical standards in the pharmaceutical industry.